ATE169677T1 - Neue neutrophilaktivierende faktoren - Google Patents

Neue neutrophilaktivierende faktoren

Info

Publication number
ATE169677T1
ATE169677T1 AT92309407T AT92309407T ATE169677T1 AT E169677 T1 ATE169677 T1 AT E169677T1 AT 92309407 T AT92309407 T AT 92309407T AT 92309407 T AT92309407 T AT 92309407T AT E169677 T1 ATE169677 T1 AT E169677T1
Authority
AT
Austria
Prior art keywords
methods
inhibitors
activating factors
neutrophil activating
ena
Prior art date
Application number
AT92309407T
Other languages
English (en)
Inventor
Alfred Walz
Original Assignee
Alfred Walz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Walz filed Critical Alfred Walz
Application granted granted Critical
Publication of ATE169677T1 publication Critical patent/ATE169677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92309407T 1991-10-16 1992-10-15 Neue neutrophilaktivierende faktoren ATE169677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/778,413 US5401651A (en) 1991-10-16 1991-10-16 DNA encoding ENA-78, a neutrophil activating factor

Publications (1)

Publication Number Publication Date
ATE169677T1 true ATE169677T1 (de) 1998-08-15

Family

ID=25113266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92309407T ATE169677T1 (de) 1991-10-16 1992-10-15 Neue neutrophilaktivierende faktoren

Country Status (7)

Country Link
US (2) US5401651A (de)
EP (1) EP0538030B1 (de)
JP (1) JPH05331196A (de)
AT (1) ATE169677T1 (de)
AU (1) AU660192B2 (de)
CA (1) CA2080525A1 (de)
DE (1) DE69226592T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US5627156A (en) * 1994-09-23 1997-05-06 University Of Nebraska Board Of Regents Polypeptide agonists for human interleukin-8
US6410268B1 (en) * 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
AU731926B2 (en) * 1997-01-17 2001-04-05 Johnson & Johnson Medical Limited Peptides for use in wound treatment
EP0858808B1 (de) * 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptide zur Verwendung in Wundbehandlung
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
CA2305787A1 (en) * 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) * 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
JP2002506830A (ja) * 1998-03-13 2002-03-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 治療的ケモカイン受容体アンタゴニスト
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
CA2402238C (en) * 2000-03-07 2011-12-13 Japan Tobacco Inc. Polypeptides having neutrophil stimulating activity
US20060233748A1 (en) * 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
US20050059584A1 (en) * 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7378098B2 (en) * 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US20070116669A1 (en) * 2002-09-13 2007-05-24 Chemokine Therapeutics Corporation Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
US7368425B2 (en) * 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
US6962971B2 (en) * 2001-03-16 2005-11-08 The Regents Of The University Of California Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
ATE518884T1 (de) 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
SG191716A1 (en) 2010-11-19 2013-08-30 Toshio Imai Neutralizing anti-ccl20 antibodies
CN103376228B (zh) * 2012-04-27 2016-02-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种检测或辅助检测放射性肺纤维化的试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3133305B2 (ja) * 1987-11-19 2001-02-05 ノバルティス・アクチエンゲゼルシャフト 好中球活性化因子

Also Published As

Publication number Publication date
EP0538030B1 (de) 1998-08-12
DE69226592T2 (de) 1999-03-04
CA2080525A1 (en) 1993-04-17
EP0538030A3 (de) 1994-05-04
US5591718A (en) 1997-01-07
EP0538030A2 (de) 1993-04-21
DE69226592D1 (de) 1998-09-17
AU2706992A (en) 1993-04-22
AU660192B2 (en) 1995-06-15
JPH05331196A (ja) 1993-12-14
US5401651A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DE69226592D1 (de) Neue neutrophilaktivierende Faktoren
ATE122724T1 (de) Festsetzung von biomolekülen durch verstärkte niederschlagelektrophorese.
DE69433301D1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
DE69936946D1 (de) Reinigung von Antikörpern durch Ionenaustauschchromatographie
DE69534235D1 (de) Cytokin lerk-7
NO20043419L (no) Nytt cytokin, zcytor17-ligand
DE3485895D1 (de) Verwendung von durch emulgatoren stabilisierte kohlenwasserstoffschlaemme als brennstoffe.
ATE161536T1 (de) Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer
DE3687328D1 (de) Vorort-bestimmung des gesamtkohlenstoffgehalts zur auswertung von muttergestein.
FI961251A0 (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
AR008508A1 (es) METODO PARA LOGRAR UNA EXPRESION ESPECíFICA MESoFILA DE UNA SECUENCIA DE NUCLEOTIDOS CODIFICANTE EN PLANTAS, CONTROLADA POR UN PROMOTOR , CASETES DE EXPRESION, VECTORES RECOMBINANTES Y MICROORGANISMOS QUE CONTIENEN DICHOS PROMOTORES, UTILIZACION DE DICHOS VECTORES Y PROMOTORES Y PROCEDIMIENTO PARA P
DK0593618T3 (da) Screeningsassay til påvisning af DNA-bindende molekyler
SE9301270D0 (sv) Biosensor
ATE201416T1 (de) Varianten von adhäsionsmoleküle für blutplättchen
TW200716746A (en) Methods for identifying a compound modulating the binding between polypeptides
DE69836823D1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
ATE204172T1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
ATE176668T1 (de) Neue 9-n-bicyclische nucleosidverbindungen nützlich als selektive inhibitoren von proinflammatorische cytokinen
SE9602822D0 (sv) New receptor
DE69316079D1 (de) Verfahren zur Dechlorierung von höheren Chlormethanen
DE59203070D1 (de) Verfahren zur Abtrennung von Aromaten durch Extraktivdestillation.
FR2638439B1 (fr) Ascenseur transbordeur notamment pour le franchissement des voies urbaines par les pietons
FI971086A7 (fi) Kinaasia sitova proteiini ja sen käyttö
DE59914155D1 (de) Neue peptidfragmente zur reinigung von proteinen